{"entity":{"type":"insider","cik":"0001342826","url":"/insider/0001342826","json_url":"/insider/0001342826.json","name":"Erck Stanley C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":111,"n_filings":25,"first":"2008-07-31","last":"2025-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Erck Stanley C","source":"filing","n_filings":25,"first_seen":"2008-07-31","last_seen":"2025-08-13"}],"transactions":[{"id":4226636,"accession":"0000905148-25-002875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-002875","line_url":"/filing/0000905148-25-002875#line-1","is_derivative":false,"issuer_cik":"0001287098","issuer_name":"MAXCYTE, INC.","issuer_ticker":"MXCT","issuer_name_source":null,"issuer_url":"/issuer/0001287098","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.3722,"price_display":"1.37","price_state":"stated","total_value":137220.0,"total_display":"137,220.00","total_whole":"137,220","shares_owned_after":398328.0,"shares_owned_after_display":"398,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-13","scope":"insider"},{"id":2662612,"accession":"0001415889-24-026144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-026144","line_url":"/filing/0001415889-24-026144#line-2","is_derivative":false,"issuer_cik":"0001287098","issuer_name":"MAXCYTE, INC.","issuer_ticker":"MXCT","issuer_name_source":null,"issuer_url":"/issuer/0001287098","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47689.0,"shares_display":"47,689","price_per_share":3.72,"price_display":"3.72","price_state":"stated","total_value":177403.08,"total_display":"177,403.08","total_whole":"177,403","shares_owned_after":269118.0,"shares_owned_after_display":"269,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"},{"id":2900661,"accession":"0001415889-24-024454","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-024454","line_url":"/filing/0001415889-24-024454#line-4","is_derivative":false,"issuer_cik":"0001287098","issuer_name":"MAXCYTE, INC.","issuer_ticker":"MXCT","issuer_name_source":null,"issuer_url":"/issuer/0001287098","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21607.0,"shares_display":"21,607","price_per_share":3.71,"price_display":"3.71","price_state":"stated","total_value":80161.97,"total_display":"80,161.97","total_whole":"80,162","shares_owned_after":269118.0,"shares_owned_after_display":"269,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-02","scope":"insider"},{"id":2900653,"accession":"0001415889-24-024454","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024454","line_url":"/filing/0001415889-24-024454#line-2","is_derivative":false,"issuer_cik":"0001287098","issuer_name":"MAXCYTE, INC.","issuer_ticker":"MXCT","issuer_name_source":null,"issuer_url":"/issuer/0001287098","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26082.0,"shares_display":"26,082","price_per_share":3.78,"price_display":"3.78","price_state":"stated","total_value":98589.96,"total_display":"98,589.96","total_whole":"98,590","shares_owned_after":269118.0,"shares_owned_after_display":"269,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-01","filed_date":"2024-10-02","scope":"insider"},{"id":2330821,"accession":"0001415889-24-022941","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-022941","line_url":"/filing/0001415889-24-022941#line-4","is_derivative":false,"issuer_cik":"0001287098","issuer_name":"MAXCYTE, INC.","issuer_ticker":"MXCT","issuer_name_source":null,"issuer_url":"/issuer/0001287098","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29767.0,"shares_display":"29,767","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":118174.99,"total_display":"118,174.99","total_whole":"118,175","shares_owned_after":269118.0,"shares_owned_after_display":"269,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-05","scope":"insider"},{"id":2330813,"accession":"0001415889-24-022941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-022941","line_url":"/filing/0001415889-24-022941#line-2","is_derivative":false,"issuer_cik":"0001287098","issuer_name":"MAXCYTE, INC.","issuer_ticker":"MXCT","issuer_name_source":null,"issuer_url":"/issuer/0001287098","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17922.0,"shares_display":"17,922","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":73480.2,"total_display":"73,480.20","total_whole":"73,480","shares_owned_after":269118.0,"shares_owned_after_display":"269,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"},{"id":4956490,"accession":"0001209191-21-059557","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-21-059557","line_url":"/filing/0001209191-21-059557","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42829.0,"shares_display":"42,829","price_per_share":176.1468797917299,"price_display":"176.15","price_state":"stated","total_value":7544194.7146,"total_display":"7,544,194.71","total_whole":"7,544,195","shares_owned_after":36242.0,"shares_owned_after_display":"36,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-05","scope":"insider","n_lines":10},{"id":4741387,"accession":"0001209191-21-059552","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-21-059552","line_url":"/filing/0001209191-21-059552","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":175.1033436,"price_display":"175.10","price_state":"stated","total_value":8580063.8364,"total_display":"8,580,063.84","total_whole":"8,580,064","shares_owned_after":36521.0,"shares_owned_after_display":"36,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider","n_lines":23},{"id":4838407,"accession":"0001209191-21-045558","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-25","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9969.0,"shares_display":"9,969","price_per_share":217.8405,"price_display":"217.84","price_state":"stated","total_value":2171651.9445,"total_display":"2,171,651.94","total_whole":"2,171,652","shares_owned_after":34252.0,"shares_owned_after_display":"34,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838404,"accession":"0001209191-21-045558","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-24","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7616.0,"shares_display":"7,616","price_per_share":212.2878,"price_display":"212.29","price_state":"stated","total_value":1616783.8848,"total_display":"1,616,783.88","total_whole":"1,616,784","shares_owned_after":59226.0,"shares_owned_after_display":"59,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838401,"accession":"0001209191-21-045558","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-23","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7423.0,"shares_display":"7,423","price_per_share":218.7717,"price_display":"218.77","price_state":"stated","total_value":1623942.3291,"total_display":"1,623,942.33","total_whole":"1,623,942","shares_owned_after":26829.0,"shares_owned_after_display":"26,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838398,"accession":"0001209191-21-045558","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-22","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5190.0,"shares_display":"5,190","price_per_share":215.7406,"price_display":"215.74","price_state":"stated","total_value":1119693.714,"total_display":"1,119,693.71","total_whole":"1,119,694","shares_owned_after":47215.0,"shares_owned_after_display":"47,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838394,"accession":"0001209191-21-045558","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-21","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5031.0,"shares_display":"5,031","price_per_share":219.7605,"price_display":"219.76","price_state":"stated","total_value":1105615.0755,"total_display":"1,105,615.08","total_whole":"1,105,615","shares_owned_after":21798.0,"shares_owned_after_display":"21,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838390,"accession":"0001209191-21-045558","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-20","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4466.0,"shares_display":"4,466","price_per_share":214.7581,"price_display":"214.76","price_state":"stated","total_value":959109.6746,"total_display":"959,109.67","total_whole":"959,110","shares_owned_after":52405.0,"shares_owned_after_display":"52,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838388,"accession":"0001209191-21-045558","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-19","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4242.0,"shares_display":"4,242","price_per_share":211.2084,"price_display":"211.21","price_state":"stated","total_value":895946.0328,"total_display":"895,946.03","total_whole":"895,946","shares_owned_after":66842.0,"shares_owned_after_display":"66,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838385,"accession":"0001209191-21-045558","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-18","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2994.0,"shares_display":"2,994","price_per_share":216.9188,"price_display":"216.92","price_state":"stated","total_value":649454.8872,"total_display":"649,454.89","total_whole":"649,455","shares_owned_after":44221.0,"shares_owned_after_display":"44,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838381,"accession":"0001209191-21-045558","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-17","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2355.0,"shares_display":"2,355","price_per_share":213.3849,"price_display":"213.38","price_state":"stated","total_value":502521.4395,"total_display":"502,521.44","total_whole":"502,521","shares_owned_after":56871.0,"shares_owned_after_display":"56,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838375,"accession":"0001209191-21-045558","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-16","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1970.0,"shares_display":"1,970","price_per_share":210.2299,"price_display":"210.23","price_state":"stated","total_value":414152.903,"total_display":"414,152.90","total_whole":"414,153","shares_owned_after":71084.0,"shares_owned_after_display":"71,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4838371,"accession":"0001209191-21-045558","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-21-045558","line_url":"/filing/0001209191-21-045558#line-15","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001342826","owner_name":"Erck Stanley C","owner_display_name":"Erck Stanley C","owner_url":"/insider/0001342826","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":675.0,"shares_display":"675","price_per_share":221.5281,"price_display":"221.53","price_state":"stated","total_value":149531.4675,"total_display":"149,531.47","total_whole":"149,531","shares_owned_after":20495.0,"shares_owned_after_display":"20,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"}],"collapsed":true,"next_cursor":"2021-07-02|4838371","ledger_fault":false,"count":{"value":111,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":96,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":111},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001287098","name":"MAXCYTE, INC.","url":"/issuer/0001287098","role":"Director","n_filings":4,"first_seen":"2024-09-05","last_seen":"2025-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001000694","name":"NOVAVAX INC","url":"/issuer/0001000694","role":"Director, Officer (President and CEO)","n_filings":19,"first_seen":"2011-08-11","last_seen":"2021-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Director","n_filings":1,"first_seen":"2009-03-16","last_seen":"2009-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001125001","name":"IOMAI CORP","url":"/issuer/0001125001","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2008-07-31","last_seen":"2008-07-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001342826","retrieved_at":"2026-08-24T02:02:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}